Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening

BACKGROUND: Currently available screening tools for left ventricular (LV) hypertrophy (LVH) and systolic dysfunction (LVSD) are either expensive (echocardiography) or perform suboptimally (B‐type natriuretic peptide [BNP]). It is unknown whether newer biomarkers are associated with LVH and LVSD and...

Descripción completa

Detalles Bibliográficos
Autores principales: Xanthakis, Vanessa, Larson, Martin G., Wollert, Kai C., Aragam, Jayashri, Cheng, Susan, Ho, Jennifer, Coglianese, Erin, Levy, Daniel, Colucci, Wilson S., Michael Felker, G., Benjamin, Emelia J., Januzzi, James L., Wang, Thomas J., Vasan, Ramachandran S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886765/
https://www.ncbi.nlm.nih.gov/pubmed/24200688
http://dx.doi.org/10.1161/JAHA.113.000399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886765/
https://www.ncbi.nlm.nih.gov/pubmed/24200688
http://dx.doi.org/10.1161/JAHA.113.000399

Ejemplares similares